Kestra Medical Technologies, Ltd. (KMTS)
Kestra Medical Technologies, Ltd. (KMTS) is a healthcare company (medical instruments & supplies) based in the United States. The share price is $28.27, up 1.07% on the day, which values the company at $1.68B. Price as of 18 Nov 2026, 12:34 UTC, from Yahoo Finance.
Key facts
- Share price
- $28.27+1.07% today
- Market value
- $1.68B
- Funk Score
- 61/100
- Sector
- Healthcare
Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.
Kestra Medical Technologies, Ltd. in more detail
KMTS trades at -13.8× next year's expected earnings, 15.8× sales.
Its Funk Score is 61 out of 100 (financial strength 6.4, profitability 2.0, growth 10.0, each out of 10).
In its favour: Altman Z in the safe zone; Operating margin is expanding. Worth checking: Beneish M-score flags the accounts; Thin interest cover.
Kestra Medical Technologies, Ltd. (KMTS): questions and answers
What is Kestra Medical Technologies, Ltd.'s market cap?
Kestra Medical Technologies, Ltd. is valued at $1.68B at a share price of $28.27.
How fast is Kestra Medical Technologies, Ltd. growing?
Over the last three fiscal years Kestra Medical Technologies, Ltd.'s revenue grew 131.9% a year.
Does KMTS pay a dividend?
Kestra Medical Technologies, Ltd. does not currently pay a regular dividend.
When does Kestra Medical Technologies, Ltd. report earnings next?
Kestra Medical Technologies, Ltd.'s next earnings report is expected on December 14, 2026. The date comes from the market data feed and companies do move it.
Learn to read these numbers
All stocks guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Analyst price targets and ratings: what they mean
An analyst price target is a research analyst's estimate of where a share price will be at a set horizon, such as twelve months; a rating such as buy or hold is that analyst's recommendation. A consensus is an average or median of the targets a data provider has collected. Studies have found targets on average well above later prices.
- Free cash flow and FCF yield explained
Free cash flow is the cash a business generates from operations minus what it spends on equipment, buildings and other long-lived assets. Free-cash-flow yield divides that cash by the company's market value: $5 billion of free cash flow on a $100 billion company is a 5% yield. It is cash available to owners and lenders, not profit.
Cite this page
Funkfolio, “Kestra Medical Technologies, Ltd. (KMTS) stock: price, valuation and fundamentals”, data as of 18 November 2026. https://funkfolio.com/stock/KMTS
Underlying data: Yahoo Finance; company filings with the SEC.